Literature DB >> 12186258

Regenerative medicine through mesenchymal stem cells for bone and cartilage repair.

Danièle Noël1, Farida Djouad, Christian Jorgense.   

Abstract

Bone and cartilage defects are common features of bone fracture and joint diseases, such as rheumatoid arthritis or osteoarthritis, that have great social and economic impact on the aging occidental population. Despite progress in orthopedic surgery, bone and cartilage repair is a major challenge as large defects will not spontaneously heal. Recent investigations on the stromal mesenchymal stem cell (MSC) offer a new perspectivefor bone and cartilage tissue engineering. However, the standard offull healing is extremely demanding and may be achieved through the engineering of MSCs combined with scaffolds and growth factors as recombinant proteins, or using a gene therapy approach.

Entities:  

Mesh:

Year:  2002        PMID: 12186258

Source DB:  PubMed          Journal:  Curr Opin Investig Drugs        ISSN: 1472-4472


  43 in total

Review 1.  Tomorrow's skeleton staff: mesenchymal stem cells and the repair of bone and cartilage.

Authors:  W R Otto; J Rao
Journal:  Cell Prolif       Date:  2004-02       Impact factor: 6.831

Review 2.  Ethical issues in molecular medicine of relevance to surgeons.

Authors:  Mark Bernstein; Joseph Bampoe; Abdallah S Daar
Journal:  Can J Surg       Date:  2004-12       Impact factor: 2.089

3.  Carboxylated superparamagnetic iron oxide particles label cells intracellularly without transfection agents.

Authors:  Volker Mailänder; Myriam Ricarda Lorenz; Verena Holzapfel; Anna Musyanovych; Karin Fuchs; Markus Wiesneth; Paul Walther; Katharina Landfester; Hubert Schrezenmeier
Journal:  Mol Imaging Biol       Date:  2008-02-23       Impact factor: 3.488

Review 4.  Inflammatory bowel disease: Moving toward a stem cell-based therapy.

Authors:  Giacomo Lanzoni; Giulia Roda; Andrea Belluzzi; Enrico Roda; Gian Paolo Bagnara
Journal:  World J Gastroenterol       Date:  2008-08-07       Impact factor: 5.742

Review 5.  Therapeutic application of mesenchymal stem cells in bone and joint diseases.

Authors:  Yi Liu; Jianmei Wu; Youming Zhu; Jinxiang Han
Journal:  Clin Exp Med       Date:  2012-11-03       Impact factor: 3.984

6.  Comparison of osteogenic potentials of visceral and subcutaneous adipose-derived cells of rabbits.

Authors:  Ioana A Peptan; Liu Hong; Jeremy J Mao
Journal:  Plast Reconstr Surg       Date:  2006-04-15       Impact factor: 4.730

7.  Effect of Dynamic Culture and Periodic Compression on Human Mesenchymal Stem Cell Proliferation and Chondrogenesis.

Authors:  Ting Guo; Li Yu; Casey G Lim; Addison S Goodley; Xuan Xiao; Jesse K Placone; Kimberly M Ferlin; Bao-Ngoc B Nguyen; Adam H Hsieh; John P Fisher
Journal:  Ann Biomed Eng       Date:  2015-11-17       Impact factor: 3.934

8.  Activin A expression regulates multipotency of mesenchymal progenitor cells.

Authors:  Farida Djouad; Wesley M Jackson; Brent E Bobick; Sasa Janjanin; Yingjie Song; George T J Huang; Rocky S Tuan
Journal:  Stem Cell Res Ther       Date:  2010-05-04       Impact factor: 6.832

9.  Leptin Potentiates BMP9-Induced Osteogenic Differentiation of Mesenchymal Stem Cells Through the Activation of JAK/STAT Signaling.

Authors:  Bo Zhang; Lijuan Yang; Zongyue Zeng; Yixiao Feng; Xi Wang; Xiaoxing Wu; Huaxiu Luo; Jing Zhang; Meng Zhang; Mikhail Pakvasa; William Wagstaff; Fang He; Yukun Mao; Kevin Qin; Huimin Ding; Yongtao Zhang; Changchun Niu; Meng Wu; Xia Zhao; Hao Wang; Linjuan Huang; Dayao Shi; Qing Liu; Na Ni; Kai Fu; Aravind Athiviraham; Jennifer Moriatis Wolf; Michael J Lee; Kelly Hynes; Jason Strelzow; Mostafa El Dafrawy; Yayi Xia; Tong-Chuan He
Journal:  Stem Cells Dev       Date:  2020-03-09       Impact factor: 3.272

10.  Development of bone and cartilage in tissue-engineered human middle phalanx models.

Authors:  Yoshitaka Wada; Mitsuhiro Enjo; Noritaka Isogai; Robin Jacquet; Elizabeth Lowder; William J Landis
Journal:  Tissue Eng Part A       Date:  2009-12       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.